Matt McGraner - Feb 15, 2022 Form 4 Insider Report for NexPoint Residential Trust, Inc. (NXRT)

Role: EVP, Chief Investment Officer
Signature: /s/ Brian Mitts, as attorney-in-fact
Stock symbol: NXRT
Transactions as of: Feb 15, 2022
Transactions value $: -$689,762
Form type: 4
Date filed: 2/17/2022, 05:26 PM
Previous filing: Dec 17, 2021
Next filing: Feb 25, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NXRT	Common Stock	Options Exercise		+24.5K	+20.46%		144K	Feb 15, 2022	Direct	F1
transaction	NXRT	Common Stock	Tax liability	-$690K	-8.45K	-5.87%	$81.59	136K	Feb 15, 2022	Direct
holding	NXRT	Common Stock						13.1K	Feb 15, 2022	By 401(k) plan	F2
holding	NXRT	Common Stock						17K	Feb 15, 2022	By limited liability company	F3
holding	NXRT	Common Stock						109K	Feb 15, 2022	By Trust	F4
holding	NXRT	Common Stock						454	Feb 15, 2022	By dividend reinvestment plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NXRT	Restricted Stock Units	Options Exercise	$0	-24.5K	-100%	$0.00^*	0	Feb 15, 2022	Common Stock	24.5K		Direct	F1, F5
transaction	NXRT	Restricted Stock Units	Award	$0	+44.1K		$0.00	44.1K	Feb 17, 2022	Common Stock	44.1K		Direct	F1, F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one share of common stock of NexPoint Residential Trust, Inc.
F2	Includes shares acquired through the issuer's employee benefit plan.
F3	These shares are held by a limited liability company in which Mr. McGraner owns an indirect minority interest. Mr. McGraner disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.
F4	These shares are held in a trust. Mr. McGraner is the trustee of the trust. Mr. McGraner disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.
F5	On February 15, 2018, the reporting person was granted 97,899 restricted stock units which vested 25% on February 15, 2019, 25% on February 15, 2020, 25% on February 15, 2021, and 25% on February 15, 2022. Settlement will generally occur within 10 days of vesting and may at the discretion of the Compensation Committee be settled in cash.
F6	On February 17, 2022, the reporting person was granted 44,051 restricted stock units which will vest 20% on February 17, 2023, 20% on February 17, 2024, 20% on February 17, 2025, 20% on February 17, 2026 and 20% on February 17, 2027. Settlement will generally occur within 10 days of vesting and may at the discretion of the Compensation Committee be settled in cash.